134, Swetayan Industrial Estate, Opp. Bahuchar Party Plot, Kathwada - Singarva Road, Kathwada, Ahmedabad - 382430 +91 95868 58886 info@molsyns.com

N-Nitroso Rimegepant Impurity 2

Home N-Nitroso Rimegepant Impurity 2
N-Nitroso Rimegepant Impurity 2

N-Nitroso Rimegepant Impurity 2

Product Type
Impurity Standards
CAT. No.
MRL-R25005
CAS. No.
NA
Mol. F.
C10H15N5O
Mol. Wt.
221.26
Synonyms
NA
Chemical Name
N-(2-Aminopyridin-3-yl)-N-(piperidin-4-yl)nitrous amide
Stock Status
Please Enquire
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Rimegepant. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Rimegepant is a medication used for the acute treatment of migraine headaches in adults. Chemically, it is a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist. Rimegepant works by blocking the activity of CGRP, a neuropeptide involved in the transmission of pain signals associated with migraines. By inhibiting CGRP receptors, rimegepant helps alleviate migraine symptoms, including pain, nausea, and sensitivity to light and sound. It is available in oral tablet form and is often prescribed for individuals experiencing moderate to severe migraines. As a relatively new class of migraine medications, CGRP antagonists like rimegepant provide an alternative for those who may not tolerate or respond well to other migraine treatments. The use of rimegepant is typically guided by healthcare professionals based on the specific needs and medical history of the patient. Buy high quality N-Nitroso Rimegepant Impurity 2 from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N-Nitroso Rimegepant Impurity 2

Request for Quotation : N-Nitroso Rimegepant Impurity 2

Get In Touch

134, Swetayan Industrial Estate, Opp. Bahuchar Party Plot, Kathwada - Singarva Road, Kathwada, Ahmedabad - 382430

Copyright © 2024 Molsyns Research. All Rights Reserved.

Developed by Softweb Technologies